Progress in the Management of Advanced Thoracic Malignancies in 2017-Reference-Cited by-同舟云学术

Progress in the Management of Advanced Thoracic Malignancies in 2017

Published:2018-03 Issue:3 Volume:13 Page:301-322
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Ferrara Roberto,Mezquita Laura,Besse Benjamin

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference140 articles.

1. Pembrolizumab in patients with extensive-stage small-cell lung cancer: results from the phase Ib KEYNOTE-028 study;Ott;J Clin Oncol,2017

2. Avelumab for metastatic or locally advanced previously treated solid tumours (JAVELIN Solid Tumor): a phase 1a, multicohort, dose-escalation trial;Heery;Lancet Oncol,2017

3. A phase II study of pembrolizumab for patients with previously treated advanced thymic epithelial tumor;Cho;J Clin Oncol,2017

4. Clinical safety and activity of pembrolizumab in patients with malignant pleural mesothelioma (KEYNOTE-028): preliminary results from a non-randomised, open-label, phase 1b trial;Alley;Lancet Oncol,2017

5. Second- or third-line nivolumab (Nivo) versus nivo plus ipilimumab (Ipi) in malignant pleural mesothelioma (MPM) patients: updated results of the IFCT-1501 MAPS2 randomized phase II trial;Zalcman;Ann Oncol,2017

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of a DNA-methylome-based signature for prognosis prediction in driver gene-negative lung adenocarcinoma;Cancer Letters;2024-07

2. Uncommon de novo EGFRT790M-Mutant NSCLC characterized with unique genetic Features: Clinical response and acquired resistance to the third-generation EGFR-TKIs treatment;Lung Cancer;2024-04

3. PDL1 and molecular biomarkers expression in non-small cell lung cancer in Tunisian patients;Monaldi Archives for Chest Disease;2023-11-03

4. Pharmacokinetic and dose‐finding study of osimertinib in patients with impaired renal function and low body weight;Cancer Science;2023-02-14

5. From targeted therapy to a novel way: Immunogenic cell death in lung cancer;Frontiers in Medicine;2022-12-23